azaftig

05/03/2002 - "So far, very little is known about the mechanism underlying loss of fat depot in mice or weight loss in patients excreting azaftig. "
05/03/2002 - "Administration of azaftig to mice results in weight loss that is associated with loss of fat depot. "
01/27/1999 - "The azaftig-like immunoreactivity was present in 69.2% (9/13) of patients with weight loss, but only in 27.0% (3/11) of weight-stable cancer or AIDS patients and none of the control subjects (n = 8)."
01/27/1999 - "We report the presence of azaftig in the urine of cancer and AIDS patients experiencing weight loss, but not in the control or weight-stable subjects. "
01/27/1999 - "We have isolated and partially characterized a proteoglycan (named azaftig) from the urine of a cancer patient experiencing weight loss. "

01/27/1999 - "The azaftig-like immunoreactivity was present in 69.2% (9/13) of patients with weight loss, but only in 27.0% (3/11) of weight-stable cancer or AIDS patients and none of the control subjects (n = 8)."
01/27/1999 - "We report the presence of azaftig in the urine of cancer and AIDS patients experiencing weight loss, but not in the control or weight-stable subjects. "
01/27/1999 - "We have isolated and partially characterized a proteoglycan (named azaftig) from the urine of a cancer patient experiencing weight loss. "
01/01/1999 - "Azaftig, a urinary proteoglycan from a cachectic cancer patient, causes profound weight loss in mice."
05/03/2002 - "Azaftig is an urinary proteoglycan present in some cancer and AIDS patients experiencing weight loss. "

01/27/1999 - "The azaftig-like immunoreactivity was present in 69.2% (9/13) of patients with weight loss, but only in 27.0% (3/11) of weight-stable cancer or AIDS patients and none of the control subjects (n = 8)."
01/27/1999 - "We report the presence of azaftig in the urine of cancer and AIDS patients experiencing weight loss, but not in the control or weight-stable subjects. "
05/03/2002 - "Azaftig is an urinary proteoglycan present in some cancer and AIDS patients experiencing weight loss. "
01/01/1999 - "We have isolated and partially characterized a proteoglycan (azaftig) from the urine of cancer and AIDS patients experiencing weight loss. "

01/01/1999 - "When given to mice, the purified azaftig resulted in a significant decrease in body weight and body fat without any effect on appetite. "